Xcel e-Prime Energy Natural Gas Antitrust Settlement

e-Prime Energy and Xcel Energy will pay $2.5 million as part of a settlement to resolve claims of a price-fixing plan between multiple utility companies. This settlement will benefit companies and consumers who bought natural gas from Xcel Energy Inc. or e-Prime Energy Marketing Inc. in Colorado between 1st January 2000 and 31st October 2002.… Continue reading Xcel e-Prime Energy Natural Gas Antitrust Settlement

Auto Parts Antitrust Litigation Settlement

TK Holdings, a Takata subsidiary has agreed to resolve claims it conspired with other manufacturers to increase the price of vehicle safety systems by allocating $84 million in its bankruptcy reorganization plan. The settlement terms will benefit direct buyers of occupant safety systems like airbags, seat belts, steering systems, steering wheels, safety electronic systems, and… Continue reading Auto Parts Antitrust Litigation Settlement

$264M EpiPen Antitrust Class Action Settlement

A class-action lawsuit has been brought against Mylan alleging the company of associating with Pfizer and other companies to increase the cost of the EpiPen. These epinephrine injectors can save people from life-threatening allergic reactions. While Mylan, a Vitaris company manufactures the branded variant of Epipen, there are also authorized generics available in the market.… Continue reading $264M EpiPen Antitrust Class Action Settlement

Glumetza Antitrust Litigation Settlement

A class action settlement has been reached against three pharmaceutical companies wherein they have decided to pay $453 million to resolve the claims that they suppressed generic variants of Glumetza. FDA first approved Glumetza in 2005 as a once-daily extended-release variant of metformin owned by Depomed (presently known as Assertio) and Santarus which was subsequently… Continue reading Glumetza Antitrust Litigation Settlement

Restasis Drugs Price Litigation Class Action Settlement

Allergan has given its nod to a class action claim worth $30 million for resolving a lawsuit that has accused them of using anti-competitive tactics for raising the price of Restasis eye drops. This settlement is expected to benefit both third-party payors like insurers and employers and consumers. Restasis is an eye drop medicine that… Continue reading Restasis Drugs Price Litigation Class Action Settlement